13
Orphan Designations
0
FDA Approvals
20
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| B-cell chronic lymphocytic leukemia | dacetuzumab | Orphan Designation | - |
| Bicervical bicornuate uterus with patent cervix and vagina | brentuximab vedotin | Orphan Designation | - |
| Hodgkins lymphoma | Chimeric monoclonal antibody to CD30 (anti-CD30 antibody) | Orphan Designation | - |
| MALT lymphoma | brentuximab vedotin | Orphan Designation | - |
| acute myeloid leukemia | vadastuximab talirinelintuzumab | Orphan Designation | - |
| adult T-cell leukemia/lymphoma | brentuximab vedotin | Orphan Designation | - |
| anaplastic large cell lymphoma | Chimeric monoclonal antibody to CD30 (anti-CD30 antibody) | Orphan Designation | - |
| carbon monoxide-induced delayed encephalopathy | brentuximab vedotin | Orphan Designation | - |
| distichiasis with congenital anomalies of the heart and peripheral vasculature | brentuximab vedotin | Orphan Designation | - |
| enteropathy-associated T-cell lymphoma | brentuximab vedotin | Orphan Designation | - |
| extranodal nasal NK/T cell lymphoma | brentuximab vedotin | Orphan Designation | - |
| multiple congenital anomalies-hypotonia-seizures syndrome 2 | brentuximab vedotin | Orphan Designation | - |
| multisystemic smooth muscle dysfunction syndrome | brentuximab vedotin | Orphan Designation | - |
| mycosis fungoides | brentuximab vedotin | Orphan Designation | - |
| myelodysplastic syndrome | lintuzumab | Orphan Designation | - |
| natal teeth-intestinal pseudoobstruction-patent ductus syndrome | brentuximab vedotin | Orphan Designation | - |
| neurodevelopmental disorder with progressive spasticity and brain abnormalities | brentuximab vedotin | Orphan Designation | - |
| plasma cell myeloma | dacetuzumab | Orphan Designation | - |
| primary cutaneous anaplastic large cell lymphoma | Chimeric monoclonal antibody to CD30 (anti-CD30 antibody) | Orphan Designation | - |
| spinal muscular atrophy with congenital bone fractures 2 | brentuximab vedotin | Orphan Designation | - |